Health
16 Oct 2026
Iambic Raises $150 Million IPO to Fund AI‑Powered Cancer Drugs
Iambic Therapeutics pulled in $150 million in an IPO, aiming to use the capital to advance its AI‑driven platform that seeks to create next‑generation cancer treatments.
Read more